Related Experiment Video
Updated: Jul 9, 2026

Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants
Published on: January 26, 2019
Mitral valve repair for infective endocarditis: Kobe experience
Yukikatsu Okada1, Takeo Nakai1, Takashi Muro1
1Heart Valve Center, Midori Hospital, Kobe, Japan.
Objectives:
We retrospectively analyzed our experience of mitral valve repair for native mitral valve endocarditis in a single institution.
Methods:
From January 1991 to October 2011, 171 consecutive patients underwent surgery for infective endocarditis. Of these, 147 (86%) had mitral valve repair. At the time of surgery, 98 patients had healed (group A) and 49 had active infective endocarditis (group B). Repair procedures included resection of all infected tissue and thick restricted post-infection tissue, leaflet and annulus reconstruction with treated autologous pericardium, chordal reconstruction with polytetrafluoroethylene sutures, and ring annuloplasty if necessary. Fifty-two (35%) patients required concomitant procedures. The study endpoints were overall survival, freedom from reoperation, and freedom from valve-related events. The median follow-up was 78 months.
Results:
There was one hospital death (hospital mortality 0.7%). Survival at 10 years was 88.5% ± 3.5% with no significant difference between the two groups (p = 0.052). Early reoperation was required in 4 patients in group B due to persistent infection or procedure failure. Freedom from reoperation at 5 years was 99% ± 1.0% in group A and 89.6 ± 4.0% in group B (p = 0.024). Event-free survival at 10 years was 79.3% ± 4.8% (group A: 83.4% ± 5.9%, group B: 72.6% ± 6.9%, p = 0.010).
Conclusions:
Mitral valve repair was highly successful using autologous pericardium, chordal reconstruction, and ring annuloplasty if required. Long-term results were acceptable in terms survival, freedom from reoperation, and event-free survival. Mitral valve repair is recommended for mitral infective endocarditis in most patients.
Insights
Mitral valve repair for infective endocarditis demonstrated high success rates, with excellent long-term survival and freedom from reoperation. This procedure is recommended for most patients with mitral valve endocarditis.
Area of Science:
- Cardiovascular Surgery
- Infective Diseases
- Valvular Heart Disease
Background:
- Native mitral valve endocarditis poses significant risks, often necessitating surgical intervention.
- Mitral valve repair aims to preserve native valve function and improve patient outcomes.
Purpose of the Study:
- To evaluate the efficacy and long-term results of mitral valve repair in patients with native mitral valve endocarditis.
- To assess overall survival, freedom from reoperation, and freedom from valve-related events after mitral valve repair.
Main Methods:
- Retrospective analysis of 147 patients undergoing mitral valve repair for infective endocarditis between 1991 and 2011.
- Patients were categorized into healed (Group A) and active (Group B) infective endocarditis groups.
- Repair techniques included infected tissue resection, leaflet/annulus reconstruction with autologous pericardium, chordal repair with polytetrafluoroethylene sutures, and annuloplasty.
Main Results:
- Hospital mortality was low (0.7%). Ten-year survival was 88.5% ± 3.5%.
- Freedom from reoperation at 5 years was significantly higher in Group A (99% ± 1.0%) compared to Group B (89.6% ± 4.0%, p=0.024).
- Ten-year event-free survival was 79.3% ± 4.8%, with better outcomes in Group A (83.4% ± 5.9%) versus Group B (72.6% ± 6.9%, p=0.010).
Conclusions:
- Mitral valve repair using autologous pericardium, chordal reconstruction, and annuloplasty is highly successful for native mitral valve endocarditis.
- Acceptable long-term outcomes regarding survival, reoperation, and valve-related events support the efficacy of this approach.
- Mitral valve repair is a recommended treatment option for the majority of patients presenting with mitral infective endocarditis.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis III: Medical Management

